7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5 Remdesivir Intermediate COVID-19
Ubonelelo ngezoRhwebo loMvelisi i-Remdesivir kunye nabaPhakathi abaNxulumeneyo nabanoMgangatho oPhezulu
I-Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
I-Trimethylsilyl Cyanide CAS 7677-24-9
I-4-Nitrophenol CAS 100-02-7
I-2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
I-Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
I-Remdesivir N-2 ePhakathi CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
I-Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Igama leMchiza | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine |
Izithethantonye | 4-Amino-7-bromopyrrolo[2,1-f][1,2,4]triazine;Ukungacoceki kwe-Remdesivir 2 |
Inombolo yeCAS | 937046-98-5 |
Inombolo yeCAT | RF-PI305 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | I-C6H5BrN4 |
Ubunzima beMolekyuli | 213.04 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMthubi oKhanya |
I-Infrared Spectrum | Iyahambelana neSakhiwo |
NMR | Iyahambelana neSakhiwo |
Ubunyulu | ≥97.0% |
Ilahleko ekomisweni | ≤1.0 |
Ukungacoceki Okukodwa | ≤1.0% |
Iintsimbi ezinzima | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi we-Remdesivir (CAS 1809249-37-3) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-7-Bromopyrrolo[2,1-f][1,2,4] triazin-4-amine (CAS 937046-98-5) nguMphakathi we-Remdesivir (CAS 1809249-37-3).I-Remdesivir lichiza le-antiviral elisebenza ngokuchasene ne-acute acute breathing syndrome 2 (SARS-CoV-2).I-Remdesivir (ekwabizwa ngokuba yiVeklury okanye i-GS-5734) yi-SARS-CoV-2 nucleotide analog RNA polymerase inhibitor eboniswe kubantu abadala nakwizigulana zabantwana (abaneminyaka eyi-12 ubudala nangaphezulu kwaye banobunzima obungama-40 kg) kunyango lwesifo se-coronavirus ngo-2019. (COVID-19) ifuna ukulaliswa esibhedlele.I-Remdesivir kufuneka ilawulwe kuphela esibhedlele okanye kwindawo yokhathalelo lwempilo ekwaziyo ukunika ukhathalelo oluqatha oluthelekiswa nokhathalelo lwasesibhedlele.I-Remdesivir yaqala yaphuhliswa njenge-anti-viral ngokuchasene nentsholongwane ye-Ebola, kodwa ukusukela oko ibonakaliswe ukuba ithobe imithwalo yentsholongwane enani leentsholongwane ze-RNA ezibandakanya i-respiratory syncytial virus (RSV) kunye ne-β-coronaviruses ezifana ne-SARS-CoV, MERS-CoV, kunye unobangela we-COVID-19, SARS-CoV-2.